Liaoning He Eye Hospital Group Past Earnings Performance
Past criteria checks 0/6
Liaoning He Eye Hospital Group's earnings have been declining at an average annual rate of -31.7%, while the Healthcare industry saw earnings growing at 2% annually. Revenues have been growing at an average rate of 8.3% per year.
Key information
-31.7%
Earnings growth rate
-38.3%
EPS growth rate
| Healthcare Industry Growth | 7.0% |
| Revenue growth rate | 8.3% |
| Return on equity | -1.4% |
| Net Margin | -1.8% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Optimistic Investors Push Liaoning He Eye Hospital Group Co., LTD. (SZSE:301103) Shares Up 42% But Growth Is Lacking
Oct 09
Liaoning He Eye Hospital Group's (SZSE:301103) Anemic Earnings Might Be Worse Than You Think
Sep 05Pinning Down Liaoning He Eye Hospital Group Co., LTD.'s (SZSE:301103) P/S Is Difficult Right Now
Aug 23Revenue & Expenses Breakdown
How Liaoning He Eye Hospital Group makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,106 | -19 | 413 | 18 |
| 30 Jun 24 | 1,149 | 9 | 414 | 14 |
| 31 Mar 24 | 1,163 | 36 | 407 | 15 |
| 31 Dec 23 | 1,185 | 64 | 394 | 13 |
| 30 Sep 23 | 1,128 | 66 | 354 | 8 |
| 30 Jun 23 | 1,108 | 69 | 343 | 4 |
| 31 Mar 23 | 1,020 | 63 | 318 | 0 |
| 01 Jan 23 | 955 | 33 | 302 | 1 |
| 30 Sep 22 | 989 | 62 | 298 | 0 |
| 30 Jun 22 | 966 | 69 | 277 | 0 |
| 31 Mar 22 | 994 | 85 | 261 | 1 |
| 01 Jan 22 | 962 | 86 | 251 | 1 |
| 30 Sep 21 | 994 | 123 | 247 | 1 |
| 30 Jun 21 | 964 | 126 | 244 | 1 |
| 31 Mar 21 | 879 | 112 | 230 | 1 |
| 31 Dec 20 | 838 | 100 | 225 | 1 |
| 31 Dec 19 | 746 | 81 | 214 | 1 |
| 31 Dec 18 | 614 | 56 | 166 | 2 |
| 31 Dec 17 | 476 | 46 | 137 | 2 |
Quality Earnings: 301103 is currently unprofitable.
Growing Profit Margin: 301103 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 301103 is unprofitable, and losses have increased over the past 5 years at a rate of 31.7% per year.
Accelerating Growth: Unable to compare 301103's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 301103 is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (-5.7%).
Return on Equity
High ROE: 301103 has a negative Return on Equity (-1.44%), as it is currently unprofitable.